| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JMRI.21194 |
| P8608 | Fatcat ID | release_jzxrwlnsurhyphuucb3wsvdglm |
| P698 | PubMed publication ID | 17968941 |
| P2093 | author name string | Gang Bao | |
| Xiaoping Hu | |||
| Leslie E W LaConte | |||
| Nitin Nitin | |||
| Daniela Caruntu | |||
| Charles J O'Connor | |||
| Omar Zurkiya | |||
| P433 | issue | 6 | |
| P921 | main subject | nanoparticle | Q61231 |
| magnetite nanoparticle | Q3870166 | ||
| P304 | page(s) | 1634-1641 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Journal of Magnetic Resonance Imaging | Q15761156 |
| P1476 | title | Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity. | |
| P478 | volume | 26 |
| Q34268745 | A responsive particulate MRI contrast agent for copper(I): a cautionary tale |
| Q34186662 | Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors |
| Q47873356 | Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress. |
| Q34287136 | Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma |
| Q30653817 | Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol. |
| Q35654360 | Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy |
| Q37209899 | Challenges in the development of magnetic particles for therapeutic applications |
| Q36441642 | Coating Evaluation and Purification of Monodisperse, Water-Soluble, Magnetic Nanoparticles Using Sucrose Density Gradient Ultracentrifugation |
| Q34833006 | Comparison of T2 and T2*-weighted MR molecular imaging of a mouse model of glioma |
| Q28395879 | Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors |
| Q37631874 | Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. |
| Q28283802 | Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers |
| Q38889627 | Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia |
| Q39388913 | Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells |
| Q42745084 | Effect of PEG molecular weight on stability, T₂ contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs) |
| Q31077828 | Effect of coating thickness of iron oxide nanoparticles on their relaxivity in the MRI. |
| Q36753384 | Efficient CD44-targeted magnetic resonance imaging (MRI) of breast cancer cells using hyaluronic acid (HA)-modified MnFe2O4 nanocrystals |
| Q46715643 | Engineered magnetic nanoparticles for biomedical applications |
| Q53269957 | Engineered water-soluble two-dimensional magnetic nanocomposites: towards highly magnetic relaxometric properties. |
| Q39778575 | Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs). |
| Q33768071 | Facile synthetic route for surface-functionalized magnetic nanoparticles: cell labeling and magnetic resonance imaging studies |
| Q38989890 | Fluorescent dye labeled iron oxide/silica core/shell nanoparticle as a multimodal imaging probe |
| Q50073061 | Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer. |
| Q35031050 | High-performance nanostructured MR contrast probes |
| Q36408332 | High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties |
| Q30979176 | How morphology influences relaxivity - comparative study of superparamagnetic iron oxide-polymer hybrid nanostructures |
| Q33842703 | Hybrid PET-optical imaging using targeted probes |
| Q57183793 | Hybrid microparticles for drug delivery and magnetic resonance imaging |
| Q59340216 | Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis |
| Q30988368 | Hydrophilic packaging of iron oxide nanoclusters for highly sensitive imaging |
| Q39080233 | Impact of Serum Proteins on MRI Contrast Agents: Cellular Binding and T2 relaxation |
| Q48253435 | In vivo aggregation-induced transition between T1 and T2 relaxations of magnetic ultra-small iron oxide nanoparticles in tumor microenvironment. |
| Q33833089 | In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent |
| Q42877109 | Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics. |
| Q57258903 | Inorganic Nanoparticles for MRI Contrast Agents |
| Q42954109 | Intracellular and extracellular T1 and T2 relaxivities of magneto-optical nanoparticles at experimental high fields. |
| Q27027859 | Iron oxide-based nanostructures for MRI and magnetic hyperthermia |
| Q51837567 | Janus plasmonic-magnetic gold-iron oxide nanoparticles as contrast agents for multimodal imaging. |
| Q40952243 | Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI. |
| Q57258891 | MRI Contrast Agents Based on Inorganic Nanoparticles |
| Q90275104 | Magnetic core-shell nanowires as MRI contrast agents for cell tracking |
| Q37375294 | Magnetic nanoparticles: surface effects and properties related to biomedicine applications |
| Q38842822 | Magnetic resonance relaxation induced by superparamagnetic particles used as contrast agents in magnetic resonance imaging: a theoretical review. |
| Q39397620 | Magnetic-nanoparticle-doped carbogenic nanocomposite: an effective magnetic resonance/fluorescence multimodal imaging probe |
| Q37990502 | Magnetite Nanoparticles for Medical MR Imaging. |
| Q43809401 | Magneto-optical nanomaterials: a SPIO-phthalocyanine scaffold built step-by-step towards bimodal imaging |
| Q53513254 | Magneto-plasmonic nanoparticles as theranostic platforms for magnetic resonance imaging, drug delivery and NIR hyperthermia applications. |
| Q37060172 | Membrane mimetic surface functionalization of nanoparticles: methods and applications |
| Q33946006 | Multifunctional Magnetic Nanoparticles for Medical Imaging Applications |
| Q42967981 | NMR relaxation in systems with magnetic nanoparticles: a temperature study. |
| Q38467265 | Nanoparticle-based multimodal PET/MRI probes |
| Q30442412 | Nanoparticles for Improving Cancer Diagnosis |
| Q28082690 | Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents |
| Q30569793 | New simulation approach using classical formalism to water nuclear magnetic relaxation dispersions in presence of superparamagnetic particles used as MRI contrast agents |
| Q34610010 | Off-resonance saturation MRI of superparamagnetic nanoprobes: theoretical models and experimental validations |
| Q38741159 | PEG coating reduces NMR relaxivity of Mn(0.5)Zn(0.5)Gd(0.02)Fe(1.98)O4 hyperthermia nanoparticles. |
| Q41634276 | PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma |
| Q46327941 | Probing T1-T2 interactions and their imaging implications through a thermally responsive nanoprobe |
| Q92442221 | Radiolabeled PET/MRI Nanoparticles for Tumor Imaging |
| Q33832576 | Release activation of iron oxide nanoparticles: (REACTION) a novel environmentally sensitive MRI paradigm |
| Q42786390 | Serial monitoring of endogenous neuroblast migration by cellular MRI. |
| Q53370042 | Spin-lock MR enhances the detection sensitivity of superparamagnetic iron oxide particles. |
| Q37883126 | Stabilization and functionalization of iron oxide nanoparticles for biomedical applications |
| Q31100414 | Stimuli-responsive magnetic nanoparticles for tumor-targeted bimodal imaging and photodynamic/hyperthermia combination therapy |
| Q36998663 | Superparamagnetic iron oxide nanoparticles alter expression of obesity and T2D-associated risk genes in human adipocytes |
| Q54943561 | Surface characterization of nanoparticles using near-field light scattering. |
| Q55073008 | Surface impact on nanoparticle-based magnetic resonance imaging contrast agents. |
| Q30975740 | Surface-Functionalized Nanoparticles by Olefin Metathesis: A Chemoselective Approach for In Vivo Characterization of Atherosclerosis Plaque |
| Q35194685 | Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy |
| Q50874953 | Surface-initiated synthesis of bulk-imprinted magnetic polymers for protein recognition. |
| Q59312613 | Targeted Nanoparticle Binding to Hydroxyapatite in a High Serum Environment for Early Detection of Heart Disease |
| Q37319940 | Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy |
| Q51136151 | The effect of superparamagnetic iron oxide nanoparticles surface engineering on relaxivity of magnetoliposome. |
| Q30937214 | Theranostic Magnetic Nanostructures (MNS) for Cancer. |
| Q37668337 | Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery |
| Q30853799 | Transverse relaxivity of iron oxide nanocrystals clustered in nanoemulsions: Experiment and theory |
| Q38126327 | Tuning the magnetic properties of nanoparticles. |
| Q30834900 | Ultrasmall, Water-Soluble Magnetite Nanoparticles with High Relaxivity for Magnetic Resonance Imaging |
| Q91801319 | Understanding the Influence of a Bifunctional Polyethylene Glycol Derivative in Protein Corona Formation around Iron Oxide Nanoparticles |
| Q34347669 | Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T(2) contrast agent with tunable proton relaxivities |
| Q42339350 | Using Nanoparticles in Medicine for Liver Cancer Imaging |
| Q36857241 | VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro |
| Q38652067 | Versatility of Pyridoxal Phosphate as a Coating of Iron Oxide Nanoparticles |
| Q41312049 | pH-Sensitive MR Responses Induced by Dendron-Functionalized SPIONs |
Search more.